{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:09:11Z","timestamp":1789578551439,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.nec.2023.02.011","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T08:14:08Z","timestamp":1681805648000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of Atypical and Anaplastic Meningiomas"],"prefix":"10.1016","volume":"34","author":[{"given":"Dominique","family":"Higgins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Komotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.nec.2023.02.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.nec.2023.02.011_bib2","first-page":"23","article-title":"Survival in patients treated for anaplastic meningioma","volume":"123","author":"Moliterno","year":"2015","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-010-0349-8","article-title":"Medical therapies for meningiomas","volume":"99","author":"Wen","year":"2010","journal-title":"J\u00a0Neurooncol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.011_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.011_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-022-04171-9","article-title":"Radiotherapy for meningiomas","volume":"160","author":"Chen","year":"2022","journal-title":"J\u00a0Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clineuro.2009.12.011","article-title":"Management of meningiomas","volume":"112","author":"Alexiou","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cncr.25591","article-title":"Anatomic location is a risk factor for atypical and malignant meningiomas","volume":"117","author":"Kane","year":"2011","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1227\/01.NEU.0000170980.47582.A5","article-title":"Diagnosis and treatment of atypical and anaplastic meningiomas: a review","volume":"57","author":"Modha","year":"2005","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2463\/mrms.2013-0132","article-title":"The rim pattern of meningioma on 3D FLAIR imaging: correlation with tumor-brain adhesion and histological grading","volume":"13","author":"Enokizono","year":"2014","journal-title":"Magn Reson Med Sci"},{"issue":"12","key":"10.1016\/j.nec.2023.02.011_bib10","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00330-008-1079-6","article-title":"New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma","volume":"18","author":"Yue","year":"2008","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ijrobp.2022.04.041","article-title":"68)Ga-DOTATATE PET: the future of meningioma treatment","volume":"113","author":"Prasad","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.nec.2023.02.011_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","article-title":"Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours","volume":"18","author":"Horbinski","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.nec.2023.02.011_bib13","first-page":"2046","article-title":"\"Malignancy\" in meningiomas: a clinicopathologic study of 116 patients, with grading implications","volume":"85","author":"Perry","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib14","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2015.1.FOCUS14757","article-title":"An evidence-based treatment algorithm for the management of WHO grade II and III meningiomas","volume":"38","author":"Sun","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.wneu.2015.04.033","article-title":"Atypical meningiomas: recurrence, reoperation, and radiotherapy","volume":"84","author":"Klinger","year":"2015","journal-title":"World Neurosurgery"},{"issue":"2","key":"10.1016\/j.nec.2023.02.011_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1440-1789.2007.00750.x","article-title":"Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma","volume":"27","author":"Bruna","year":"2007","journal-title":"Neuropathology"},{"key":"10.1016\/j.nec.2023.02.011_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1748-717X-9-38","article-title":"A\u00a0retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas","volume":"9","author":"Ferraro","year":"2014","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-010-0348-9","article-title":"A\u00a0review of malignant meningiomas: diagnosis, characteristics, and treatment","volume":"99","author":"Hanft","year":"2010","journal-title":"J\u00a0Neuroncol"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41588-022-01077-0","article-title":"SMARCE1 deficiency generates a targetable mSWI\/SNF dependency in clear cell meningioma","volume":"54","author":"St Pierre","year":"2022","journal-title":"Nat Genet"},{"issue":"7874","key":"10.1016\/j.nec.2023.02.011_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A\u00a0clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jocn.2014.10.023","article-title":"Analysis of prognostic factors and treatment of anaplastic meningioma in China","volume":"22","author":"Zhu","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.nec.2014.04.015","article-title":"Preoperative tumor embolization","volume":"25","author":"Ashour","year":"2014","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib23","first-page":"697","article-title":"Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article","volume":"114","author":"Sughrue","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib24","first-page":"977","article-title":"Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload","volume":"102","author":"Curry","year":"2005","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.nec.2023.02.011_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.clineuro.2014.06.001","article-title":"The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma. A retrospective study of a large single center patient cohort","volume":"123","author":"Hoefnagel","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.nec.2023.02.011_bib26","first-page":"483","article-title":"Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy","volume":"115","author":"Komotar","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2023.02.011_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1227\/01.NEU.0000097199.26412.2A","article-title":"Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma","volume":"54","author":"Ware","year":"2004","journal-title":"Neurosurgery"},{"issue":"11","key":"10.1016\/j.nec.2023.02.011_bib28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/neuonc\/nou098","article-title":"Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma","volume":"16","author":"Aizer","year":"2014","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib29","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/2013.9.FOCUS13325","article-title":"Atypical meningiomas: is postoperative radiotherapy indicated?","volume":"35","author":"Lee","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"8","key":"10.1016\/j.nec.2023.02.011_bib30","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00701-014-2156-z","article-title":"Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment","volume":"156","author":"Hammouche","year":"2014","journal-title":"Acta neurochirurgica"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","article-title":"Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection","volume":"75","author":"Sun","year":"2014","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib32","first-page":"811","article-title":"Radiotherapy for atypical meningiomas","volume":"115","author":"Mair","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2023.02.011_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11060-013-1219-y","article-title":"The role of adjuvant radiotherapy in atypical meningioma","volume":"115","author":"Park","year":"2013","journal-title":"J\u00a0Neurooncol"},{"issue":"11","key":"10.1016\/j.nec.2023.02.011_bib34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jocn.2010.03.036","article-title":"Treatment of atypical meningioma","volume":"17","author":"Jo","year":"2010","journal-title":"J\u00a0Clin Neurosci"},{"issue":"9","key":"10.1016\/j.nec.2023.02.011_bib35","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.6004\/jnccn.2013.0132","article-title":"National Comprehensive Cancer Network. Central nervous system cancers","volume":"11","author":"Nabors","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.nec.2023.02.011_bib36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.wneu.2014.12.037","article-title":"The role of adjuvant radiotherapy after gross total resection of atypical meningiomas","volume":"83","author":"Hasan","year":"2015","journal-title":"World Neurosurgery"},{"issue":"2","key":"10.1016\/j.nec.2023.02.011_bib37","first-page":"202","article-title":"Outcome and survival following primary and repeat surgery for World Health Organization grade III meningiomas","volume":"113","author":"Sughrue","year":"2010","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2023.02.011_bib38","first-page":"845","article-title":"Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway","volume":"86","author":"Schrell","year":"1997","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2023.02.011_bib39","first-page":"840","article-title":"Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea","volume":"86","author":"Schrell","year":"1997","journal-title":"J\u00a0Neurosurg"},{"issue":"1\u20132","key":"10.1016\/j.nec.2023.02.011_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/B:NEON.0000021827.85754.8e","article-title":"Non-resectable slow-growing meningiomas treated by hydroxyurea","volume":"67","author":"Loven","year":"2004","journal-title":"J\u00a0Neurooncol"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib41","first-page":"1034","article-title":"Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma","volume":"106","author":"Smith","year":"2007","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2023.02.011_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","article-title":"Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma","volume":"96","author":"Norden","year":"2010","journal-title":"J\u00a0Neurooncol"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1215\/15228517-2009-010","article-title":"Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)","volume":"11","author":"Wen","year":"2009","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.nec.2023.02.011_bib44","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00006123-199705000-00027","article-title":"Meningiomas: role of vascular endothelial growth factor\/vascular permeability factor in angiogenesis and peritumoral edema","volume":"40","author":"Provias","year":"1997","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.nec.2023.02.011_bib45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/neuonc\/nou148","article-title":"Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma","volume":"17","author":"Kaley","year":"2015","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/cmt.6.4.285.292","article-title":"Meningioma and hormonal influences","volume":"6","author":"Wahab","year":"2003","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-2004-817695","article-title":"Management strategy for meningioma in pregnancy: a clinical study","volume":"13","author":"Kanaan","year":"2003","journal-title":"Skull Base"},{"issue":"1","key":"10.1016\/j.nec.2023.02.011_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01050266","article-title":"A\u00a0phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study","volume":"15","author":"Goodwin","year":"1993","journal-title":"J\u00a0Neurooncol"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib49","first-page":"861","article-title":"Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone","volume":"74","author":"Grunberg","year":"1991","journal-title":"J\u00a0Neurosurg"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib50","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jnnp.55.6.486","article-title":"Mifepristone (RU 486) treatment of meningiomas","volume":"55","author":"Lamberts","year":"1992","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"4","key":"10.1016\/j.nec.2023.02.011_bib51","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/FOC-07\/10\/E12","article-title":"Targeted drug therapy for meningiomas","volume":"23","author":"Norden","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"6","key":"10.1016\/j.nec.2023.02.011_bib52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/neuonc\/not330","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","volume":"16","author":"Kaley","year":"2014","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.nec.2023.02.011_bib53","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.18632\/oncotarget.3082","article-title":"Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma","volume":"6","author":"Du","year":"2015","journal-title":"Oncotarget"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368023000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368023000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:05:38Z","timestamp":1760904338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368023000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1042368023000232"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2023.02.011","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Atypical and Anaplastic Meningiomas","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2023.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}